Procter & Gamble (P&G) has announced a $244 million investment in a new personal healthcare and digestive product manufacturing plant in Gujarat, India. The state-of-the-art facility will also serve as a major global export hub, expanding P&G's global footprint and boosting the local economy with hundreds of new jobs.
Aside from healthcare items, Procter & Gamble said it will also produce digestive products already listed in P&G's global product portfolio. The company said this week that the facility will have all of these buildings for various productions.
As per Reuters, the new plant will start its operations in a few years without giving an exact year. The company is hoping that this location in Idia will become its global export base for most of P&G's offerings.
The multi-million facility in the western part of Gujarat will sit on 50,000 square meters of land. The investment for it is set to be made via an unlisted company and will not affect any of the listed public companies within the P&G India circle.
In any case, Procter & Gamble has several plants in India, and this project is, in fact, the company's ninth factory already. The company has been producing most of its popular brands in the country, such as Whisper, Tide, Pampers, Vicks, Oral B, Head & Shoulders, Ariel, and Gillette.
"This facility will be operational over the next few years and is set to become an export hub for P&G globally, as it will help P&G India in serving consumers across the globe," the company said.
Finally, LiveMint reported that the new Procter & Gamble facility is also expected to boost the local economy. It will also generate hundreds of new jobs for the residents, so the new plant is highly beneficial in many aspects.
Photo by: P&G Multimedia


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Washington Post Publisher Will Lewis Steps Down After Layoffs
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



